RNU6-347P

Across TCGA pan-cancer cohorts, RNU6-347P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-347P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU6-347P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-347P expression acts as an unfavorable survival marker.

LUSC, COAD, and KIRC are the cancer types where RNU6-347P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.335	0.639	<.001	90	view →
COAD	OS	Tertile	All	0.140	0.871	<.001	81	view →
KIRC	DFS	Tertile	IV	0.241	0.618	.006	60	view →
BRCA	DFS	Tertile	II,III,IV	0.670	0.944	<.001	48	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
SKCM	OS	Tertile	III,IV	0.230	0.721	.004	36	view →
THCA	DFS	Tertile	II,III,IV	0.100	0.928	<.001	30	view →
LGG	OS	Tertile	All	0.584	0.891	.003	15	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-347P–LUSC (OS)

Open the LUSC breakdown →